Strategikon Pharma announced a major update to their Clinical Maestro® platform including powerful features that accelerate clinical trial planning and sourcing. This release, Clinical Maestro CORE™, focuses on expanding the ease of use and flexibility […]
Novatek Pharmaceuticals has sought emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its oral TQ Formula to treat Covid-19-infected individuals in the outpatient setting. A completely characterised, enteric-coated formulation of […]
Novavax has concluded the rolling submission to the Australian Therapeutic Goods Administration (TGA) seeking provisional approval for its Covid-19 vaccine candidate, NVX-CoV2373. The company submitted all TGA-required modules to carry out the regulatory review of […]
Lonza announced two acquisitions that will expand its exosomes development and manufacturing capabilities. The company will acquire the exosomes service unit from Exosomics, an extracellular vesicles biotech company, and a US-based exosomes manufacturing facility from […]
Synthekine and Merck have signed a global research collaboration and license agreement to develop novel cytokine-based therapeutics. Synthekine and Merck have signed a global research collaboration and license agreement to develop novel cytokine-based therapeutics. As […]